Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together
Biotech

Treasury COINS rules add biotech, spares China licensing deals

Despite the sweeping scope of the ban covering various drug modalities, biopharma business development teams can breathe a measured sigh of relief.
Angus Liu Oct 22, 2026 11:36pm
Merck

Merck and Moderna post phase 3 cancer vaccine data early

Oct 22, 2026 4:45pm
From Scientific Hypothesis to Clinical Practice The Next Chapter for CLDN182

The next chapter of CLDN18.2-directed innovation

Brought to you by Astellas Pharma US
baton handoff in track and field race

Menarini gets Georgiamune preclinical cancer drug in $1B deal

Oct 22, 2026 10:50am
Aligning drug discovery around patient benefit from the outset Connecting human insights to better decisions

Aligning drug discovery around patient benefit from the outset: Connecting human insights to better decisions

Brought to you by IQVIA Laboratories
AbbVie

AbbVie posts phase 3 HS win but falls short of expectations

Oct 22, 2026 10:39am